Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury

BACKGROUND: Activated complement system is known to mediate neuroinflammation and neurodegeneration following exposure to hypoxic-ischemic insults. Therefore, inhibition of the complement activation cascade may represent a potential therapeutic strategy for the management of ischemic brain injury. D...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Li, Yansong, Dalle Lucca, Shawn L, Simovic, Milomir, Tsokos, George C, Dalle Lucca, Jurandir J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867804/
https://www.ncbi.nlm.nih.gov/pubmed/20380727
http://dx.doi.org/10.1186/1742-2094-7-24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867804/
https://www.ncbi.nlm.nih.gov/pubmed/20380727
http://dx.doi.org/10.1186/1742-2094-7-24

Ejemplares similares